637362-21-1

Basic information

• Product Name: TERT-BUTYL 5-CHLOROSPIRO[INDOLINE-3,4'-PIPERIDINE]-1'-CARBOXYLATE
• Synonyms: TERT-BUTYL 5-CHLOROSPIRO[INDOLINE-3,4'-PIPERIDINE]-1'-CARBOXYLATE;tert-butyl 5-chlorospiro[indoline-3,4'-piperidine]-1'-carboxylat;tert-butyl 5-chlorospiro[1,2-dihydroindole-3,4'-piperidine]-1'-carboxylate;tert-Butyl 5-chloro-1,2-dihydrospiro[indole-3,4'-piperidine]-1'-carboxylate
• CAS NO: 637362-21-1
• Molecular Formula: C₁₇H₂₃ClN₂O₂
• Molecular Weight: 322.834
• Mol File: 637362-21-1.mol

Chemical Properties

• Boiling Point: 452.7±45.0 °C(Predicted)
• Appearance: /
• Density: 1.23±0.1 g/cm3(Predicted)
• PKA: 4.59±0.20(Predicted)
• CAS DataBase Reference: TERT-BUTYL 5-CHLOROSPIRO[INDOLINE-3,4'-PIPERIDINE]-1'-CARBOXYLATE(CAS DataBase Reference)
• NIST Chemistry Reference: TERT-BUTYL 5-CHLOROSPIRO[INDOLINE-3,4'-PIPERIDINE]-1'-CARBOXYLATE(637362-21-1)
• EPA Substance Registry System: TERT-BUTYL 5-CHLOROSPIRO[INDOLINE-3,4'-PIPERIDINE]-1'-CARBOXYLATE(637362-21-1)

Safety Data

• Hazardous Substances Data: 637362-21-1(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
TERT-BUTYL 5-CHLOROSPIRO[INDOLINE-3,4'-PIPERIDINE]-1'-CARBOXYLATE is used as a key intermediate in the synthesis of various drugs due to its unique spiro-structure and functional groups. Its presence in the molecular framework can influence the biological activity and pharmacological properties of the resulting compounds.
Used in Drug Development:
TERT-BUTYL 5-CHLOROSPIRO[INDOLINE-3,4'-PIPERIDINE]-1'-CARBOXYLATE is used as a potential therapeutic agent for the treatment of various diseases and conditions. Its structural features may contribute to its ability to interact with biological targets, such as receptors, enzymes, or other proteins, thereby modulating their activity and potentially leading to therapeutic effects.
Used in Medicinal Chemistry Research:
TERT-BUTYL 5-CHLOROSPIRO[INDOLINE-3,4'-PIPERIDINE]-1'-CARBOXYLATE serves as a valuable compound in medicinal chemistry research, where it can be used to explore structure-activity relationships and optimize the design of new drug candidates. Its unique spiro-structure and functional groups provide a foundation for further chemical modifications and the development of more potent and selective agents.

Upstream product

• 79099-07-3 N-tert-butyloxycarbonylpiperidin-4-one 
• 138022-91-0 tert-butyl 4-(methoxymethylene)piperidine-1-carboxylate 
• 637362-20-0 tert-butyl 5-chlorospiro[indole-3,4'-piperidine]-1'-carboxylate 

Downstream Products

• 1172587-88-0 tert-butyl 5-chloro-1-((5R,7R)-5-methyl-7-(4-nitrobenzoyloxy)-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)spiro[indoline-3,4'-piperidine]-1'-carboxylate 
• 1322047-91-5 [5-chloro-1'-[(E)-3-(2,3-dichlorophenyl)allyl]spiro[indoline-3,4'-piperidine]-1-yl]-(2-chloro-4-pyridyl)methanone 

Relevant articles and documents

S PIROINDOLINE COMPOUNDS FOR USE AS ANTHELMINTHI CS

This invention relates to spiroindoline compounds for the treatment of helminth infections and the treatment of parasitosis, such as caused by helminth infections. This invention also relates to uses of the compounds to make medicaments and treatments com

PYRIMIDYL CYCLOPENTANES AS AKT PROTEIN KINASE INHIBITORS

The present invention provides compounds of Formula (I) including tautomers, resolved enantiomers, resolved diastereomers, solvates, metabolites, salts and pharmaceutically acceptable prodrugs thereof. Also provided are methods of using the compounds of this invention as Akt protein kinase inhibitors and for the treatment of Akt-mediated diseases, for example, hyperproliferative diseases such as cancer.

SPIROINDOLINEPIPERIDINE DERIVATIVES

Insecticidal, acaricidal, nematicidal or molluscicidal compounds of formula (I) wherein Y is a single bond, C=O, C=S or C=(O)q where q is 0, 1 or 2; and R1, R2, R3, R4, R8, R9 an